IBRT17055 / BBI-DSP7888-201G / Nimish MohileResearch Question:
Does the drug DSP-7888 help patients with glioblastoma?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
This is an event driven, adaptive design, a randomized, active-controlled, multicenter,
open-label, parallel groups, Phase 3 study of DSP-7888 Dosing Emulsion plus Bevacizumab
versus Bevacizumab alone in patients with recurrent or progressive glioblastoma multiforme
(GBM) following treatment with first line therapy consisting of surgery and radiation
with or without chemotherapy.
Lead Researcher (Principal Investigator)
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search